MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from senior
convertible notes
$150,000K
Proceeds from sale of
common stock from...
$82,370K
Proceeds from sale of
common stock from...
$7,788K
Net income (loss)
$163,055K
Increase in accrued
expenses
$100,771K
Proceeds from exercise of
stock options
$6,389K
Amortization of intangible
$13,872K
Stock-based compensation
$13,832K
Change in contingent
consideration
-$6,501K
(decrease) increase in
accounts payable
$3,329K
Depreciation
$677K
Change in right-of-use
assets
$438K
Amortization of debt finance
costs
$398K
Provision for current
expected credit losses
-$252K
Net cash provided by
financing activities
$238,453K
Net cash provided by
(used in) operating...
$175,046K
Canceled cashflow
$8,094K
Canceled cashflow
$128,079K
Net (decrease)
increase in cash and cash...
$105,069K
Canceled cashflow
$308,430K
Payment of debt issuance
costs associated with...
$5,729K
Payment of employee
withholding taxes on vested...
$1,988K
Payment of contingent
consideration liabilities
$189K
Rou financing lease
fees
$188K
Maturity of short-term
investments
$55,293K
Increase in account
receivables
$90,924K
Deferred income taxes
-$25,797K
Change in fair value of
equity securities
-$5,364K
Increase in inventory
$3,478K
Increase in prepaid
expenses and other...
$2,061K
Decrease in operating
lease liabilities
-$308K
Gain on liquidation
of foreign entity
$86K
Payment of contingent
liability
$61K
Net cash provided by
(used in) investing...
-$308,430K
Canceled cashflow
$55,293K
Acquisitions of businesses,
net of cash acquired
$308,511K
Purchase of short-term
investments
$47,952K
Investment in equity
securities
$5,000K
Purchase of equipment
$2,260K
Back
Back
Cash Flow
source: myfinsight.com
CorMedix Inc. (CRMD)
CorMedix Inc. (CRMD)